NYSE · LLY
Eli Lilly and Company
$1,373.00+$84.70 (+6.57%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.51% below the high.
Loading market information…
OTC · RHEPB · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Regional Health Properties, Inc.’s quoted price sits in the lower half of its reported 52-week range, 13.43% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Regional Health Properties, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Regional Health Properties, Inc. operates as an independent real estate investment firm, focusing its portfolio primarily on properties designed for senior living and long-term care. Its core business strategy involves making these specialized facilities available to independent third-party operators via leasing and subleasing arrangements. The facilities under the company's purview offer a broad spectrum of health and wellness services for both long-term and short-stay residents. These offerings include skilled nursing and assisted living care, social support programs, various forms of therapy, and other rehabilitative and medical provisions. As of December 31, 2021, the firm either owned, leased, or managed a total of 24 facilities, predominantly located in the Southeastern United States. The company was founded in 1991 and maintains its corporate headquarters in Suwanee, Georgia.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:11 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1,373.00+$84.70 (+6.57%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.51% below the high.
$275.20+$4.16 (+1.53%)
Johnson & Johnson’s quoted price sits in the upper half of its reported 52-week range, 2.09% below the high.
$290.97+$4.98 (+1.74%)
AbbVie Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.55% below the high.
A$0.01A$0.00 (0.0%)
Discovery Alaska Limited’s quoted price sits in the lower half of its reported 52-week range, 53.57% below the high.
$0.01$0.00 (0.0%)
Leeward Group Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Vie Financial Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Social Media Ventures, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Universal Apparel & Textile Company’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
